公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2005 | Lanreotide treatment in a patient with interferon-associated Graves’ ophthalmopathy | Su, D.H.; Chang, Y.C.; Liaw, S. L.; Chang, T.C. | Graefe’s Arch Clin Exp Ophthalmol | | | |
2017 | Mercury speciation and mass balances in cement production process in Taiwan, | Chou, C.P.; Chiu, C.H.; Chang, T.C.; Hsi, H.C. | The 13th International Conference on Mercury as a Global Pollutant | | | |
1994 | Quantum confinement effects of Si/SiGe strained-layer superlattices grown by an ultrahigh vacuum/chemical vapor deposition technique | Chang, T.C.; Chang, C.Y.; Jung, T.G.; Chen, P.A.; Tsai, W.C.; Wang, P.J.; Chen, Y.F.; Pan, S.C.; YANG-FANG CHEN | Journal of Materials Science: Materials in Electronics | 1 | 2 | |
2006 | Slow-release lanreotide in Graves’ ophthalmopathy: A double-blind randomized, placebo-controlled clinical trial. | Chang, T.C.; Liao, S.L. | J. Endocrinol. Invest | | | |